Makoto Iijima Selected Research

Makoto Iijima Research Topics

Disease

6	Neoplasms (Cancer) 07/2022 - 04/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 08/2021 - 04/2010
4	Ulcerative Colitis 04/2021 - 11/2019
4	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 04/2002
3	Pathologic Constriction (Stenosis) 10/2021 - 06/2004
2	Neoplasm Metastasis (Metastasis) 04/2021 - 01/2017
2	Infections 01/2021 - 10/2020
2	Fibrosis (Cirrhosis) 01/2019 - 09/2010
2	Hemorrhage 12/2018 - 01/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2022
1	Esophageal Squamous Cell Carcinoma 07/2022
1	Diverticulum 01/2022
1	Choledocholithiasis 10/2021
1	Pancreatic Diseases (Pancreatic Disease) 08/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2021
1	Diarrhea 04/2021
1	Adenocarcinoma 04/2021
1	Colitis 04/2021
1	Hyperbilirubinemia 01/2021
1	Ascites 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Amebic Liver Abscess 12/2020
1	Esophageal and Gastric Varices (Esophageal Varices) 11/2020
1	Blister (Bulla) 11/2020
1	Abscess 11/2020
1	Chronic Hepatitis C 10/2020
1	Virus Diseases (Viral Diseases) 10/2020
1	Ulcer 06/2020
1	Alopecia (Baldness) 01/2020
1	Leukopenia 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Fatty Liver 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Bradycardia 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Hereditary Hemorrhagic Telangiectasia 12/2018
1	Abdominal Aortic Aneurysm 02/2018
1	Inflammation (Inflammations) 02/2018
1	Hyperplasia 01/2018
1	Anemia 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Thoracoabdominal Aortic Aneurysm 05/2014
1	Heart Failure 01/2013

Drug/Important Bio-Agent (IBA)

3	SteroidsIBA 10/2021 - 02/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2010
2	SodiumIBA 04/2021 - 01/2019
2	Biological ProductsIBA 04/2021 - 04/2002
2	Proteins (Proteins, Gene)FDA Link 04/2010 - 04/2002
2	acarboxyprothrombin (PIVKA)IBA 04/2010 - 04/2002
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Therapeutic UsesIBA 08/2021
1	Immune Checkpoint InhibitorsIBA 04/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021
1	Pemetrexed (MTA)FDA Link 04/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2021
1	pembrolizumabIBA 04/2021
1	Carboplatin (JM8)FDA LinkGeneric 04/2021
1	Serum AlbuminIBA 01/2021
1	SofosbuvirIBA 01/2021
1	velpatasvirIBA 01/2021
1	BilirubinIBA 01/2021
1	CeramidesIBA 01/2021
1	Heparinoids (Heparinoid)IBA 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 12/2020
1	glecaprevir and pibrentasvirIBA 10/2020
1	tofacitinibIBA 06/2020
1	2-mercaptopurineIBA 01/2020
1	Nudix HydrolasesIBA 01/2020
1	NucleotidesIBA 01/2020
1	Thioguanine (Tioguanine)FDA Link 01/2020
1	Immunologic Factors (Immunomodulators)IBA 11/2019
1	Propofol (Diprivan)FDA LinkGeneric 01/2019
1	dapagliflozinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 02/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2017

Therapy/Procedure

7	Therapeutics 07/2022 - 02/2010
2	Oral Administration 10/2021 - 12/2020
2	Drug Therapy (Chemotherapy) 04/2021 - 02/2007
2	Catheters 01/2015 - 02/2010
1	Salvage Therapy 07/2022
1	Photochemotherapy (Photodynamic Therapy) 07/2022
1	Stents 10/2021
1	Endoscopes 03/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021
1	Aftercare (After-Treatment) 11/2020
1	Remission Induction 11/2020
1	Radiofrequency Ablation 12/2018
1	Punctures 12/2018
1	Conservative Treatment 01/2018
1	Perioperative Period 01/2018
1	Combined Modality Therapy 01/2017
1	Sutures (Suture) 05/2014
1	Heart-Assist Devices 01/2013